# Low Vitamin K Status in Patients with Psoriasis Vulgaris: A Pilot Study

**Authors:** Simona R. Gheorghe, Tamás Ilyés, Gabriela A. Filip, Ana S. Dănescu, Teodora L. Timiș, Meda Orăsan, Irina Stamate, Alexandra M. Crăciun, Ciprian N. Silaghi

PMC · DOI: 10.3390/biomedicines12061180 · 2024-05-26

## TL;DR

This study finds that patients with psoriasis have lower vitamin K status compared to healthy individuals, regardless of whether they have metabolic syndrome.

## Contribution

The study is the first to report decreased vitamin K status in psoriasis patients using extrahepatic vitamin K-dependent proteins.

## Key findings

- The ucOC/cOC ratio was higher in psoriasis patients compared to controls.
- MGP levels were lower in psoriasis patients with metabolic syndrome compared to controls with metabolic syndrome.
- Vitamin D levels did not differ between groups.

## Abstract

Psoriasis vulgaris (PV) is a disease characterized by skin manifestations and systemic inflammation. There are no published studies to date on vitamin K status assessed by extrahepatic vitamin K-dependent proteins [e.g., osteocalcin (OC) and matrix Gla protein (MGP)] in patients with PV, even if vitamin K was found to promote wound contraction and decrease the healing time of the skin. Metabolic syndrome (MS), a comorbidity of PV, was found to influence vitamin K status, and vitamin D was found to be involved in the pathogenesis of PV. Therefore, our aim was to assess the status of vitamins K and D in subjects with PV. We enrolled 44 patients with PV and 44 age- and sex-matched subjects as a control group (CG), of which individuals with MS were designated the CG with MS subgroup. Furthermore, the PV patients were stratified into two subgroups: those with MS (n = 20) and those without MS (n = 24). In addition to the quantification of vitamin D and MGP in all subjects, the uncarboxylated OC/carboxylated OC (ucOC/cOC) ratio was also assessed as an inversely proportional marker of vitamin K status. We found an increased ucOC/cOC ratio in the PV group compared to CG but also a greater ucOC/cOC ratio in the PV with MS subgroup than in the CG with MS subgroup. MGP was decreased in the PV with MS subgroup compared to CG with MS subgroup. There was no difference in the vitamin D concentration between the groups. This is the first study to report decreased vitamin K status in patients with PV, independent of the presence of MS.

## Linked entities

- **Proteins:** bglap2 (bone gamma-carboxyglutamate (gla) protein (osteocalcin) 2)
- **Chemicals:** vitamin K (PubChem CID 5280483)
- **Diseases:** metabolic syndrome (MONDO:0000816)

## Full-text entities

- **Genes:** BGLAP (bone gamma-carboxyglutamate protein) [NCBI Gene 632] {aka BGP, OC, OCN}, MGP (matrix Gla protein) [NCBI Gene 4256] {aka GIG36, MGLAP, NTI}
- **Diseases:** skin manifestations (MESH:D012877), PV (MESH:D011565), MS (MESH:D024821), systemic inflammation (MESH:D007249)
- **Chemicals:** vitamin D (MESH:D014807), Vitamin K (MESH:D014812), vitamins K and D (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11200760/full.md

---
Source: https://tomesphere.com/paper/PMC11200760